Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 2 |
2021 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Lancet. 2021 Nov 13;398(10313):1811-1824. doi: 10.1016/S0140-6736(21)02188-7. Epub 2021 Oct 18.
Lancet. 2021.
PMID: 34672967
Clinical Trial.
Sarcopenia in Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study.
Pechmann LM, Jonasson TH, Canossa VS, Trierweiler H, Kisielewicz G, Petterle RR, Moreira CA, Borba VZC.
Pechmann LM, et al.
Int J Endocrinol. 2020 Oct 29;2020:7841390. doi: 10.1155/2020/7841390. eCollection 2020.
Int J Endocrinol. 2020.
PMID: 33178269
Free PMC article.
Item in Clipboard
Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus.
Pechmann LM, Petterle RR, Moreira CA, Borba VZC.
Pechmann LM, et al.
Arch Endocrinol Metab. 2021 Nov 24;65(6):801-810. doi: 10.20945/2359-3997000000418. Epub 2021 Nov 11.
Arch Endocrinol Metab. 2021.
PMID: 34762788
Free PMC article.
Item in Clipboard
Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12-week randomized controlled trial.
Vianna AGD, Lacerda CS, Pechmann LM, Polesel MG, Marino EC, Scharf M, Detsch JM, Marques K, Sanches CP.
Vianna AGD, et al. Among authors: pechmann lm.
Diabetes Obes Metab. 2020 Apr;22(4):501-511. doi: 10.1111/dom.13913. Epub 2019 Dec 3.
Diabetes Obes Metab. 2020.
PMID: 31709738
Clinical Trial.
Item in Clipboard
A randomized controlled trial to compare the effects of sulphonylurea gliclazide MR (modified release) and the DPP-4 inhibitor vildagliptin on glycemic variability and control measured by continuous glucose monitoring (CGM) in Brazilian women with type 2 diabetes.
Vianna AGD, Lacerda CS, Pechmann LM, Polesel MG, Marino EC, Faria-Neto JR.
Vianna AGD, et al. Among authors: pechmann lm.
Diabetes Res Clin Pract. 2018 May;139:357-365. doi: 10.1016/j.diabres.2018.03.035. Epub 2018 Mar 26.
Diabetes Res Clin Pract. 2018.
PMID: 29596951
Clinical Trial.
Item in Clipboard
Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial.
Vianna AGD, de Lacerda CS, Pechmann LM, Polesel MG, Marino EC, Borba VZC, Barreto FC.
Vianna AGD, et al. Among authors: pechmann lm.
Diabetol Metab Syndr. 2017 May 15;9:35. doi: 10.1186/s13098-017-0232-2. eCollection 2017.
Diabetol Metab Syndr. 2017.
PMID: 28515791
Free PMC article.
Item in Clipboard
Cite
Cite